Ultrasound monitoring of extant adnexal masses in the era of type 1 and type 2 ovarian cancers: Lessons learned from ovarian cancer screening trials

Eleanor L. Ormsby, Edward J. Pavlik, John P. McGahan

Research output: Contribution to journalReview articlepeer-review

3 Scopus citations

Abstract

Women that are positive for an ovarian abnormality in a clinical setting can have either a malignancy or a benign tumor with probability favoring the benign alternative. Accelerating the abnormality to surgery will result in a high number of unnecessary procedures that will place cost burdens on the individual and the health delivery system. Surveillance using serial ultrasonography is a reasonable alternative that can be used to discover if changes in the ovarian abnormality will occur that favor either a malignant or benign interpretation. Several ovarian cancer screening trials have had extensive experiences with changes in subclinical ovarian abnormalities in normal women that can define growth, stability or resolution and give some idea of the time frame over which changes occur. The present report examines these experiences and relates them to the current understanding of ovarian cancer ontology, presenting arguments related to the benefits of surveillance.

Original languageEnglish
Article number10
JournalDiagnostics
Volume7
Issue number2
DOIs
StatePublished - Jun 1 2017

Bibliographical note

Publisher Copyright:
© 2017 by the authors.

Keywords

  • Cancer
  • Monitoring
  • Ovary
  • Screening
  • Serial ultrasonography
  • Surveillance

ASJC Scopus subject areas

  • Clinical Biochemistry

Fingerprint

Dive into the research topics of 'Ultrasound monitoring of extant adnexal masses in the era of type 1 and type 2 ovarian cancers: Lessons learned from ovarian cancer screening trials'. Together they form a unique fingerprint.

Cite this